Literature DB >> 15905701

CD4+CD25+ T cells regulate colonic localization of CD4 T cells reactive to a microbial antigen.

Tomohiro Watanabe1, Masashi Yamori, Toru Kita, Tsutomu Chiba, Yoshio Wakatsuki.   

Abstract

BACKGROUND: In patients with inflammatory bowel diseases, T-cell activation driven by microflora has been implicated as a mechanism causing clonal expansion and infiltration of CD4+ T cells in colonic lamina propria (LP). We explored a regulatory mechanism preventing infiltration of CD4+ T cells specific to a microbe-associated antigen in the gut.
METHODS: SCID mice were reconstituted with CD4+ T cells specific to ovalbumin (OVA) and were orally administered with Escherichia coli engineered to produce OVA.
RESULTS: OVA-specific CD4+ T cells (KJ1-26+) were recruited to colonic LP in an Ag-dependent manner, which was inhibited by adoptive transfer of naturally occurring CD4+CD25+ T (Treg) cells. KJ1-26+ T cells and Treg cells are localized preferentially to the colonic follicles that contain dendritic cells. In mice given Treg cells, LP CD4+ T cells showed a decrease in proliferative and interferon gamma response and an increase in transforming growth factor beta1 response to OVA stimulation. Treg cells inhibited both antigenic activation of effector CD4+ T cells and class II/CD80/CD86 up-regulation of dendritic cells.
CONCLUSION: : Treg cells suppress recruitment of CD4+ T cells specific to a microbe-associated antigen to LP, which was associated with colocalization of effector CD4+ T cells and Treg cells in colonic follicles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905701     DOI: 10.1097/01.mib.0000163696.26969.e4

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  7 in total

Review 1.  Peritoneal damage: the inflammatory response and clinical implications of the neuro-immuno-humoral axis.

Authors:  Tarik Sammour; Arman Kahokehr; Mattias Soop; Andrew G Hill
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

2.  Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis.

Authors:  Holm H Uhlig; Janine Coombes; Christian Mottet; Ana Izcue; Claire Thompson; Andrea Fanger; Andrea Tannapfel; Jason D Fontenot; Fred Ramsdell; Fiona Powrie
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

3.  Inhibition of Pim-1 kinase ameliorates dextran sodium sulfate-induced colitis in mice.

Authors:  Yue-Ming Shen; Yan Zhao; Ya Zeng; Lu Yan; Bo-Lin Chen; Ai-Min Leng; Yi-Bin Mu; Gui-Ying Zhang
Journal:  Dig Dis Sci       Date:  2012-04-01       Impact factor: 3.199

4.  Periportal and sinusoidal liver dendritic cells suppressing T helper type 1-mediated hepatitis.

Authors:  Tomohiro Watanabe; Hiroaki Katsukura; Tsutomu Chiba; Toru Kita; Yoshio Wakatsuki
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

5.  Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.

Authors:  Tomohiro Watanabe; Naoki Asano; Peter J Murray; Keiko Ozato; Prafullakumar Tailor; Ivan J Fuss; Atsushi Kitani; Warren Strober
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

6.  SUMOylation pathway alteration coupled with downregulation of SUMO E2 enzyme at mucosal epithelium modulates inflammation in inflammatory bowel disease.

Authors:  Salman Ahmad Mustfa; Mukesh Singh; Aamir Suhail; Gayatree Mohapatra; Smriti Verma; Debangana Chakravorty; Sarika Rana; Ritika Rampal; Atika Dhar; Sudipto Saha; Vineet Ahuja; C V Srikanth
Journal:  Open Biol       Date:  2017-06       Impact factor: 6.411

Review 7.  Intestinal Regulatory T Cells as Specialized Tissue-Restricted Immune Cells in Intestinal Immune Homeostasis and Disease.

Authors:  Justin Jacobse; Jing Li; Edmond H H M Rings; Janneke N Samsom; Jeremy A Goettel
Journal:  Front Immunol       Date:  2021-08-04       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.